Latest News for: intravenous
Edit
Opdivo® (nivolumab) Intravenous Infusion Approved in South Korea in Combination with Yervoy® (ipilimumab) for the Treatment of Adult Patients with Unresectable or Metastatic Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer (ONO Pharmaceutical Co Ltd)
Public Technologies 24 Feb 2026
) ... (Headquarters. Osaka, Japan; President and COO ... nivolumab) Intravenous Infusion ("Opdivo"), an anti-PD-1 antibody, on February 23 from the Ministry of Food and Drug Safety (MFDS) in South Korea, in combination with Yervoy® (generic name.
Edit
FDA Approves VUEWAY® (gadopiclenol) Solution for Injection, Intravenous Use, for Use in Neonates and Infants
PR Newswire 23 Feb 2026
Food and Drug Administration (FDA) has approved the extension of the current VUEWAY® (gadopiclenol) solution for injection, intravenous use, for use in neonates and infants ... VUEWAY® (gadopiclenol) injection for intravenous use .
Edit
Intravenous Infusions PLC receives nod to raise GH¢50m to recapitalize
B & FT Online 18 Feb 2026
Shareholders of Intravenous Infusions PLC has approved the rights issue to raise GH¢50 million to recapitalise the operations of the company ... Chairman of the Board of Intravenous Infusions PLC, Dr ...
Edit
Dhofar Pharmaceutical Industries supplies first Omani made IV and dialysis solutions to market
Muskat Daily 11 Feb 2026
Edit
Hastings Tribune
28 Jan 2026
Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for ...
Hastings Tribune
28 Jan 2026
Edit
Eisai submits Marketing Authorisation Variation to EMA for intravenous maintenance dosing every four weeks with Leqembi® (lecanemab)
PR Newswire 26 Jan 2026
Following the initial phase with treatment every two weeks for 18 months, intravenous (IV) maintenance dosing with treatment every four weeks is approved in the United Kingdom, China, the U.S.
Edit
First child death reported from flu this season in Virginia
Wtop 15 Jan 2026
Flu season has taken a grim turn in Virginia, as the state’s health department has reported the first death of a child caused by complications associated with influenza ... “Typically, activity starts in about October, maybe November ... Source .
Edit
Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients with Unresectable or Metastatic Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer (ONO Pharmaceutical Co Ltd)
Public Technologies 14 Jan 2026
nivolumab) Intravenous Infusion ("Opdivo"), an anti-PD-1 antibody, on January 14 from the Taiwan Food and Drug Administration (TFDA) in Taiwan, in combination with ipilimumab, for the ...
Edit
Intravenous (IV) Solutions Market Size to Reach USD 25.10 Billion by 2033, Growing at a ...
Nasdaq Globe Newswire 09 Jan 2026
Global Intravenous (IV) Solutions Market growth is driven by rising hospitalization rates, ...
Edit
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV) (Form 8-K) (Ovid Therapeutics Inc)
Public Technologies 18 Dec 2025
Edit
Intravenous Immunoglobulin Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | ...
GetNews 17 Dec 2025
The Key Intravenous Immunoglobulin Companies in the market include - Takeda, Mitsubishi Tanabe Pharma, AbbVie, Prothya Biosolutions, and others ... Some of the key facts of the Intravenous Immunoglobulin Market Report..
Edit
JFDA Bans Entry of Intravenous (+NAD) Products for Personal Use
Petra 10 Dec 2025
10 (Petra) The Jordan Food and Drug Administration (JFDA) said it has issued a circular prohibiting the entry of intravenous (+NAD) products for personal use, under legal liability, due to the absence ...
- 1